To identify genes that can, in high copy number, suppress the temperature-sensitivity of end5-1 cells, we transformed these cells (AMY66) with a high copy number (2µ) yeast genomic library and selected for loss of temperature-sensitivity. All of the suppressor plasmids contained either END5 or LAS17/BEE1 (Figure 1a) . The smallest LAS17 insert to have suppressor activity contained no other open reading frame. LAS17 encodes the yeast homologue of a human protein defective in patients with Wiskott-Aldrich Syndrome [6] . In these patients, haematopoietic cells have a defective cortical actin cytoskeleton [7] . WASp is a proline-rich protein that interacts with Cdc42p, a low molecular weight GTPase important in regulating the cortical actin cytoskeleton [8] [9] [10] .
Results and discussion
To identify genes that can, in high copy number, suppress the temperature-sensitivity of end5-1 cells, we transformed these cells (AMY66) with a high copy number (2µ) yeast genomic library and selected for loss of temperature-sensitivity. All of the suppressor plasmids contained either END5 or LAS17/BEE1 (Figure 1a) . The smallest LAS17 insert to have suppressor activity contained no other open reading frame. LAS17 encodes the yeast homologue of a human protein defective in patients with Wiskott-Aldrich Syndrome [6] . In these patients, haematopoietic cells have a defective cortical actin cytoskeleton [7] . WASp is a proline-rich protein that interacts with Cdc42p, a low molecular weight GTPase important in regulating the cortical actin cytoskeleton [8] [9] [10] .
The 2µ-LAS17 plasmid (pAM155) suppressed the temperature-sensitivity of end5-1 cells (RH2075), but a centromeric plasmid containing LAS17 (cen-LAS17, pAM161) did not have this ability. We tested the ability of 2µ-LAS17 to suppress the temperature-sensitivity of mutants defective in actin (act1-1, RH2150), fimbrin . In addition, we tested for suppression of the temperature-sensitivity of cdc42-1 (WAY299) [15] , because mammalian WASp binds mammalian Cdc42p. Suppression of temperature-sensitivity was complete for end5-1, weak for end3-1, and absent for the other mutants tested; 2µ-END5 (pAM160) was also found to be unable to suppress temperature-sensitivity for any of the above mutants except end5-1 (and end5∆, see below). Using the endocytic marker dye lucifer yellow, 2µ-LAS17 was shown to be able to restore endocytosis to end5-1 cells at 37°C (Figure 1b) , but not at 24°C (data not shown).
To test whether the cytoskeletal defect of end5-1 cells could be corrected by LAS17, end5-1 cells bearing 2µ-LAS17 were grown at 24°C and then either left at 24°C or shifted to 37°C. F actin was visualised by staining with rhodamine-labelled phalloidin (Figure 2a ). Although the abnormal size of end5-1 cells at 37°C was corrected by 2µ-LAS17, there was no obvious change in cortical actin patch distribution at 24°C or 37°C. Some abnormalities within cortical actin patches in end5-1 mutants may have been corrected without a restoration of normal localisation. When the same experiment was carried out on wild-type cells carrying 2µ-LAS17 (Figure 2b ), the distribution of cortical actin patches was found to be perturbed in a temperature-dependent manner, and this effect of LAS17 may explain the lack of suppression seen in Figure 2a .
As End5p and Las17p are both unusually proline-rich, we tested whether overexpression of Las17p can functionally replace End5p. Neither temperature-sensitivity nor endocytosis were corrected in end5∆ cells transformed with 2µ-LAS17 ( Figure 1a and data not shown), suggesting that the correction of defects in end5-1 cells relies on residual activity of mutant End5-1p. Characterisation of the end5-1 gene showed that it has a frameshift mutation after codon 604 (of 818), leading to mistranslation for 146 codons before termination.
Las17p has been shown to localise to cortical actin patches [6] . To determine the localisation of End5p, we used the gene for green fluorescent protein (GFP) fused to the last codon of intact END5. When carried on a centromeric plasmid this END5-GFP construct is partially functional (see Materials and methods; data not shown). End5p-GFP can be seen in live cells in patches that are concentrated in small buds and putative bud sites like cortical actin patches (data not shown). In double-labelling immunofluorescence experiments, colocalisation of End5p-GFP and F actin to some, but not all, cortical patches was observed ( Figure 2c ). (a) The 2µ-LAS17 plasmid does not restore a polarised distribution of cortical actin patches to end5-1 cells. The distribution of F actin in end5-1 cells transformed with the 2µ vector or with 2µ-LAS17 was visualised by staining fixed cells with rhodamine-labelled phalloidin. Cells were kept at 24°C or shifted to 37°C for 2 h before fixation. Note that the abnormal cell size seen for end5-1 cells after shift to 37°C is corrected by 2µ-LAS17, even though a polarised distribution of cortical actin patches is not restored. (b) The 2µ-LAS17 plasmid disrupts the polarised distribution of cortical actin patches in wild-type (WT) cells. The distribution of F actin in wild-type cells (RH1800) carrying the 2µ vector or carrying 2µ-LAS17 was examined as in (a). (c) End5p-GFP localises to some, but not all, cortical actin patches. Shown are end5-1 cells expressing a partially functional End5p-GFP fusion protein from a centromeric plasmid (pAM162) double-stained with rhodamineconjugated phalloidin and with rabbit anti-GFP antibodies and FITCconjugated goat anti-rabbit IgG secondary antibodies. Cells were visualised using rhodamine-specific (phalloidin, upper panels) or FITCspecific (anti-GFP, lower panels) light filters, respectively. A few of the End5p-GFP patches do not colocalise with cortical actin patches. Deletion of the LAS17 gene was shown to block fluidphase endocytosis ( Figure 3) . Like end5 cells, las17∆ cells are temperature-sensitive (data not shown) and the 2µ-END5 construct did not suppress their temperaturesensitivity. To determine the phenotype of end5∆ las17∆ cells, we crossed a las17∆ strain to an end5∆ strain and isolated recombinant haploid spores. Whereas las17∆ and end5∆ spores formed colonies at 24°C, the las17∆ end5∆ spores germinated but formed only microcolonies (see Supplementary material published with this article on the internet), showing that some functions of End5p and Las17p in growth are redundant.
Recently, a human gene encoding a proline-rich WASpinteracting protein (WIP) was isolated using a yeast twohybrid screen [5] . WIP and End5p share a short stretch of high homology in their amino-terminal domains (in the putative actin-binding motif) and some homology in the remainder of the proteins [5] (see Supplementary material). Testing WIP deletions for interaction with WASp revealed that the carboxy-terminal 126 residues of WIP are required for binding to WASp [5] . WIP could be a human homologue of End5p. If so, it is interesting that the region missing in end5-1 shows some homology to that region in WIP which is required for interaction with WASp. It is possible that the mutant protein encoded by end5-1 interacts poorly with Las17p and overexpression of Las17p is necessary to produce sufficient interaction. We tested whether full-length Las17p and End5p interact in the yeast two-hybrid system [16] and found that they interact strongly. We then tested interactions between different parts of Las17p and End5p and showed that, in an analogous manner to WIP and WASp, the amino terminus of Las17p interacts with the carboxyl terminus of End5p (Table 1) .
We have identified LAS17 as a gene which, in high copy number, can suppress the growth defects and endocytosis defect of end5-1 mutants. We suggest that End5p and Las17p form a complex that plays a crucial role in endocytosis based on the following observations: Las17p and End5p both localise to cortical actin patches; Las17p and End5p are each required for endocytosis; suppression by 2µ-LAS17 relies on residual End5-1p function; and Las17p interacts with End5p in the yeast two-hybrid system. By analogy to the interaction of human WASp with WIP, interaction of Las17p and End5p may normally involve interaction of the amino-terminal domain of Las17p with the carboxy-terminal domain of End5p.
Materials and methods

Strains, growth conditions, genetic methods, and manipulation of DNA
Standard methods and media for yeast growth, sporulation and tetrad analysis were used [17] . All DNA manipulations were as described [18] . AMY66 is a haploid derived from a cross of RH2075 to the wildtype ade2 strain RH2878. The high-copy-number suppressor screen involved transformation of a yeast genomic DNA library (a gift of M.I. Geli, A. Wesp and H. Riezman, University of Basel) carried in the ADE2 2µ vector pASZ12 (a gift of P. Linder, University of Geneva) into AMY66 and selection for growth at 37°C on SD selective medium. Plasmids present in the resulting colonies were isolated, amplified in Escherichia coli and retransformed into AMY66 to confirm that suppression is conferred by the plasmid.
Plasmid construction
A 3 kb BamHI-SphI fragment (derived from the smallest library clone, pAM150) which contains the promoter and coding region of LAS17 was subcloned into the centromeric vector YCplac111 [19] and the 2µ-based vector YEplac181 [19] Wild type
Lucifer yellow Table 1 The carboxyl terminus of End5p interacts with the amino terminus of Las17p. Interaction between End5p and Las17p was tested using the yeast two-hybrid system. β-galactosidase (β-gal) activity was assayed to assess the strength of the interaction. Data shown here represent an average of three independent assays.
Activation domain
We constructed an END5-GFP gene fusion as follows: the S65T mutant GFP gene [20] (provided by R. Tsien, HHMI, UC San Diego) was cloned into YCplac111 to yield pAM158. The END5 gene (lacking its termination codon) was then ligated in-frame and upstream of the GFP gene in pAM158 to obtain pAM162, which complements the temperature-sensitivity of end5-1 (RH2075) but not end5∆ (RH2892), while pAM158 complements neither.
2µ-END5 (pAM160) was made by subcloning a 3.4 kb HindIII-BamHI fragment containing the promoter and entire coding region of END5 from pEND5.1 into YEplac181.
Microscopy
Fluorescence microscopy was performed using a Leica DMLB fluorescence microscope and images were captured either digitally, using an Optronix DEI-470T cooled charge-coupled device camera (Leica Pte. Ltd, Singapore), or on Kodak TMAX-400 film, using a 35 mm film camera. Cells were fixed with formaldehyde for 30 min at the temperature of growth before staining. F actin was visualised by staining with rhodamine-phalloidin (Sigma) as described [21] .
For immunofluorescence, end5-1 cells (RH2075) transformed with pAM162 were grown in SD medium at 24°C, fixed, and stained with rabbit polyclonal anti-GFP antibodies (a gift from J. Kahana and P. Silver, Dana Farber Cancer Institute, Boston, MA) followed by FITCconjugated donkey anti-rabbit IgG antibodies (Jackson Immunoresearch Laboratories) and rhodamine-phalloidin, using standard procedures. Stained cells were visualised using FITC-and rhodaminespecific light filters.
Lucifer yellow uptake assay
Assays for measuring fluid-phase endocytosis of Lucifer yellow were performed at 24°C or 37°C as described [22] .
Yeast two-hybrid interaction test
Yeast two-hybrid interactions [16] were measured using the method and kit supplied by Clontech Laboratories.
Supplementary material
Additional materials and methods, the tables of yeast strains and plasmids used in this study, the genetic data showing synthetic lethality of the end5∆ and las17∆ mutations, and the amino-acid sequence comparison of End5p and WIP are published with this article on the internet. 
Materials and methods
Construction of the END5-GFP fusion
The primers used for amplifying the GFP gene were 5′GFPC-BamHI (5′-GATAGGATCCATGAGTAAAGGAG-3′) and 3′GFP-SmaI (5′-GCGCGCCCCGGGTCATTTGTATAGTTCATCCAT-3′). Amplification with these primers creates a BamHI site immediately before the GFP start codon. The BamHI-SmaI fragment was ligated into YCplac111 to make pAM158. A HindIII-SalI fragment derived from pEND5.1 provided the 5′ upstream regulatory sequences and amino-terminus-encoding half of the END5 open reading frame. The primers used for amplifying the carboxyl-terminus-encoding half of the END5 open reading frame were E5F2 (5′-GCTCCGCCTCCACCACCAC-3′) and E5C BamHI (5′-ATGGAGGGATCCTCGCGTAAAT-3′). Amplification using these primers removes the termination codon of END5 and adds a BamHI site at this position. The fragment encoding the carboxyl terminus of END5 was digested with SalI and BamHI and ligated with a HindIII-SalI fragment (derived from pEND5.1) encoding the amino terminus of END5 to reconstruct a complete END5 gene lacking only the termination codon. This was then ligated with pAM158 cut with HindIII and BamHI to place END5 upstream of, and in frame with, the GFP gene.
Sequence of end5-1
The END5 and end5-1 genes were amplified from wild-type (RH1800) and end5-1 (RH2075) cells, respectively, using Pfu polymerase (Stratagene). Primers used to amplify the genes were END5 N (5′-AAC-CGTTTGTTGAAGAAGCCTACC-3′) and END5 C (5′-TCACAGCGAAAAGGACGGGAAGCT-3′). The PCR products were cloned into the pCR-script SK+ cloning vector (Stratagene). Several different clones of END5 and end5-1 were sequenced using an Omni base Sequencing Kit (Promega).
Yeast two-hybrid interaction test
Activation domain fusion constructs pAM173 (End5p 1-816 in pB42AD) and pAM174 (Las17p 2-266 in pB42AD) and LexA DNAbinding domain fusion constructs pAM175 (End5p 480-816 in pLexA) and pAM178 (Las17p 2-633 in pLexA) were used to transform EGY48 individually and in combinations. The DNA fragments contained in the two-hybrid fusion constructs were obtained by PCR amplification of the fragments using primers containing appropriate restriction sites.
Supplementary material Figure S1
End5p shows amino-acid sequence homology to WIP, a human WASp-interacting protein. An alignment is shown between the aminoacid sequences encoded by S. cerevisiae END5/VRP1 (Genbank accession number X87806) and human WIP (AF031588). Identical residues are shaded in black and conservative substitutions in grey. 
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